References
- Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984; 230: 232–236
- Ernsberger P., Guiliano R., Willette R. N., Reis D. J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 1990; 253: 408–418
- Head G. A., Korner P. I., Lewis S. L., Badoer E. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits. J Cardiovasc Pharmacol. 1983; 5: 945–953
- Head G. A., Burke S. L. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine. J Cardiovasc Pharmacol. 1991; 18: 819–826
- Punnen S., Urbanski R., Krieger A. J., Sapru H. N. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 1987; 422: 336–346
- Lipski J., Przybylski J., Solnicka E. Reduced hypotensive effect of clonidine after lesions of the nucleus tractus solitarii in rats. Eur J Pharmacol. 1976; 38: 19–22
- Dorward P. K., Riedel W., Burke S. L., Gipps J., Korner P. I. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res. 1985; 57: 618–633
- Malpas S. C., Shweta A., Anderson W. P.A., Head G. A. Graded increases in renal nerve activity with hypoxia in conscious rabbits: renal nerve activity and excretory responses. Am J Physiol. (in press)
- Bricca G., Dontenwill M., Molines A., Feldman J., Tibirica E., Belcourt A., Bousquet P. Rilmenidine selectivity for imidazoline receptors in human brain. Eur J Pharmacol. 1989; 163: 373–377
- Sannajust F., Head G. A. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J Cardiovasc Pharmacol. 1994; 23: 42–50
- Head G. A., Sannajust F. Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits. Fundam Clin Pharmacol. 1992; 6(suppl 1)31s–43s
- Head G. A., Godwin S. J., Sannajust F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J Hypertens. 1993; 11(suppl. 5)S322–S322
- Ernsberger P. R., Westbrooks K. L., Christen M. O., Schafer S. G. A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors. J Cardiovasc Pharmacol. 1992; 20(suppl. 4)S1–S1
- Chan C. K.S., Head G. A. Relative importance of central imidazoline receptors for the anti-hypertensive effects of moxonidine and rilmenidine. J Hypertens. 1996; 14: 855–864
- Sannajust F., Head G. A. Effect of rilmenidine on the baroreflex control of renal sympathetic nerve activity. J Hypertens. 1993; 11(suppl. 5)S328–S328
- Head G. A. Central monoamine systems and new antihypertensive agents. Clin Exp Hypertens. 1995; 17: 141–152
- Schlicker E., Armah B. I., Gothert M. Central presynaptic α2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J Cardiovasc Pharmacol. 1990; 16: 15–22